Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Viokace Generic Name & Formulations
Legal Class
Rx
General Description
Lipase/protease/amylase: 10440Units/39150Units/39150Units; 20880Units/78300Units/78300Units; tabs.
Pharmacological Class
Pancreatic enzymes (porcine).
How Supplied
Tabs—100
Manufacturer
Viokace Indications
Indications
Treatment of exocrine pancreatic insufficiency in adults due to chronic pancreatitis or pancreatectomy, in combination with a proton pump inhibitor.
Viokace Dosage and Administration
Adult
Start at the lowest recommended dose and increase gradually. Individualize based on clinical symptoms, the degree of steatorrhea present, and the fat content of the diet. Swallow whole; do not crush or chew tabs. Take with meals and sufficient fluid. Do not let any drug remain in mouth. Initially 500 lipase units/kg per meal. Max: 2500 lipase units/kg per meal (or ≤10000 lipase units/kg/day), or <4000 lipase units/g fat ingested per day. See full labeling.
Children
Not established.
Viokace Contraindications
Not Applicable
Viokace Boxed Warnings
Not Applicable
Viokace Warnings/Precautions
Warnings/Precautions
Not interchangeable with other pancrelipase products. Fibrosing colonopathy (with high doses); risk of stricture formation (monitor). Pork allergy. Potential viral transmission. Gout. Renal impairment. Hyperuricemia. Contents irritating to oral mucosa. Lactose intolerance. Pregnancy (Cat.C). Nursing mothers.
Viokace Pharmacokinetics
See Literature
Viokace Interactions
Not Applicable
Viokace Adverse Reactions
Adverse Reactions
Biliary tract stones, anal pruritus; allergic reactions.
Viokace Clinical Trials
See Literature
Viokace Note
Not Applicable
Viokace Patient Counseling
See Literature
